← FDA DRUG APPROVALS

FDA ANDA · ANDA211496

PREDNISONE

Sponsor: GENEYORK PHARMS

APPLICATION
ANDA211496
TYPE
ANDA
ORIGINAL APPROVAL
2018-12-28
LATEST ACTION
2024-06-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PREDNISONEDiscontinued
PREDNISONE 1MG · TABLET · ORAL

Approval history

2024-06-05Labeling · Supplement 4 · standardAP
2018-12-28UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →